Lyell Immunopharma (LYEL) EPS (Diluted) (2020 - 2026)
Lyell Immunopharma (LYEL) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.15 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.52 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Lyell Immunopharma | 276.08 Mn | 276.08 Mn | - | -4.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.72 |
| Dec 31, 2025 | -8.47 |
| Sep 30, 2025 | -5.59 |
| Jun 30, 2025 | -7.81 |
| Mar 31, 2025 | -8.73 |
| Dec 31, 2024 | -42.91 |
| Sep 30, 2024 | -9.71 |
| Jun 30, 2024 | -10.14 |
| Mar 31, 2024 | -5.89 |
| Dec 31, 2023 | -24.45 |
| Sep 30, 2023 | -5.57 |
| Jun 30, 2023 | -7.26 |
| Mar 31, 2023 | -6.68 |
| Dec 31, 2022 | -15.58 |
| Sep 30, 2022 | -15.17 |
| Jun 30, 2022 | -10.55 |
| Mar 31, 2022 | -14.36 |
| Dec 31, 2021 | -25,944.97 |
| Sep 30, 2021 | -5.07 |
| Jun 30, 2021 | -81.43 |